Consumer Health/OTC Healthcare industry and market research, statistics, market share

Filter Summary

Country Report

Vitamins and Dietary Supplements in the US

In the US, where healthcare is expensive and non-universal and the unemployment rate remains stubbornly high, there is a large and growing interest in preventative health care. In 2011, vitamins and dietary supplements continued to benefit from ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Weight Management in the US

At 2%, retail sales growth of weight management products was higher in 2011 than the review period average. While 2011 was a strong year for several new brands of meal replacement slimming and weight loss supplements, growth of the review period was ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Wound Care in the US

As consumers emerge from one of the most severe recessions in US history, they remain highly price-sensitive and are focused on getting the best value for their money; a trend clearly exhibited in wound care in 2011. First, consumers chose to buy ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Adult Mouth Care in the US

Driven by the dramatic growth of dry mouth remedies, current value sales in adult mouth care grew by 2% in 2011. An ageing population in the US combined with increasing usage of prescription drugs increased the incidence of dry mouth among consumers ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Analgesics in the US

After a challenging 2010 marked by a series of major product recalls, McNeil’s position only worsened in 2011. In January, the company announced that it was recalling 43 million packages of Tylenol, Benadryl, Sudafed, and Sinutab products due to ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Calming and Sleeping in the US

In January 2010, McNeil recalled nine lots of its leading brand Simply Sleep. In the following years, consumers reported that the brand had totally vanished from store shelves, forcing them to buy other brands or private label alternatives. The ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in the US

In 2011, Chattem Inc’s Allegra brand of antihistamine/allergy remedies (systemic) switched from Rx-to-OTC, representing one of the largest switches in the segment’s history. First stocked on store shelves in March, Chattem accompanied Allegra’s ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Digestive Remedies in the US

In December 2010, Johnson & Johnson’s product recall woes were majorly reinforced in digestive remedies. First, the company (in its joint venture with Merck & Co) announced it was recalling 12.3 million bottles of Mylanta because the product’s labels...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Ear Care in the US

In February 2012, Prestige Brands Inc announced that it had completed the acquisition of 17 OTC brands from GlaxoSmithKline Consumer Health in a US$660 million deal. This move stands to dramatically reshape the competitive landscape in ear care, as ...

Apr 2012 | US$900| Add to cart | View details ›

Country Report

Emergency Contraception in the US

In February 2011, global brand owner Teva Pharmaceutical Industries Ltd filed a petition with the FDA to permit the sale of its Plan B One Step over-the-counter. Since 2006, age restrictions on the sale of emergency contraceptives have required that ...

Apr 2012 | US$900| Add to cart | View details ›